Physical oil prices have dropped sharply, with refiners rejecting offers and Nigerian cargoes remaining unsold, signaling a shift from a previous bidding war to a fire sale. While physical oil prices remain high, futures still reflect a war premium, creating a disconnect between the physical market and futures pricing. Increased exports from Gulf countries and high shipping costs are influencing market dynamics. The situation remains volatile with ongoing geopolitical risks, but the physical market's current weakness may pressure funds like USO that rely on futures contracts.
Physical oil prices have shifted from a bidding war to a fire sale. For readers following energy-sector stocks, here is Pluang's market snapshot as of Nov 04, 2026 22:41 WIB: out of 79 priced US energy stocks, 6 rose and 73 fell. Marathon Petroleum Corp (MPC) dropped 7.31% to USD 396.11 with 66% sell orders, Solaredge Technologies Inc (SEDG) fell 6.45% to USD 30.76 with 100% sell orders, and Venture Global Inc. (VG) declined 6.38% to USD 12.17 with 25% sell orders.
Goldman Sachs Group, Inc. disclosed that it briefly held a combined stake exceeding 3% in Ontex Group NV shares as of October 27, 2026, with 566,115 voting rights and 1,965,157 financial instruments. However, by October 28, 2026, their combined posit...
BNP Paribas announced its monthly declaration of voting rights and shares as of October 31, 2026. The bank reported a total of 1,101,600,607 shares and an equal number of voting rights. This update is part of regulatory compliance under French commer...
Ontex disclosed that Goldman Sachs Group, Inc. crossed the 3% ownership threshold in Ontex shares on October 27, 2026, holding a combined total of 3.07% including voting rights and financial instruments. However, the next day, October 28, 2026, Goldm...
Neion Bio has appointed John A. Maga, Ph.D., as Head of Biologics and CMC to lead the development of biologic medicines using its Raptor platform, which produces proteins in transgenic chicken eggs. Maga brings over 25 years of biopharmaceutical expe...
The National Advertising Division (NAD) recommended that Good Life Meds discontinue claims about health benefits and personalization for its compounded Tirzepatide+ weight loss products after a challenge by Eli Lilly. NAD found that Good Life lacked ...
